Cullin-5 RING E3 ligase limits CD8⁺ T-cell persistence and effector responses during chronic antigen stimulation
T-cell exhaustion limits durable antitumor responses and remains a barrier to adoptive cell therapies (ACT) in solid tumors. To identify regulators of T-cell persistence, we performed genome-wide CRISPR knockout screens in primary human CD8⁺ T cells expressing an NY-ESO-1-specific T-cell receptor and subjected them to repeated tumor cell rechallenge. These screens revealed enrichment of single-guide RNAs targeting components of Cullin-RING E3 ligases, particularly Cullin-5 (CRL5) assemblies comprising CUL5, RNF7, and ARIH2. Disruption of CRL5 genes in T cells preserved cytotoxic activity and enhanced cytokine production while sustaining effector-associated transcriptional programs and suppressing exhaustion-related signatures. Pharmacologic inhibition of cullin neddylation with the NEDD8-activating enzyme inhibitor MLN4924 recapitulated CRL5 loss and enhanced T-cell effector function in vitro. In a human melanoma xenograft model, ACT with CRL5-deficient T cells improved tumor control. Together, these findings identify CRL5 as a negative regulator of T-cell fitness and a potential therapeutic target to enhance ACT durability in solid tumors.
Authors
- Justin D. Saco (ORCID: https://orcid.org/0000-0001-6466-5245)
- Nupura Kale (ORCID: https://orcid.org/0000-0002-3185-8646)
- Daniel Karin (ORCID: https://orcid.org/0000-0002-1176-2209)
- Cristina Puig-Saus (ORCID: https://orcid.org/0000-0002-3014-3649)
- Stefanie Bachl (ORCID: https://orcid.org/0009-0002-2732-2125)
- Brenda Arlene Schulman (ORCID: https://orcid.org/0000-0002-3083-1126)
- Justin J. Patten (ORCID: https://orcid.org/0000-0002-9770-7525)
- Julia C. Carnevale (ORCID: https://orcid.org/0000-0001-9410-7148)
- Ameya S. Champhekar (ORCID: https://orcid.org/0000-0002-2758-0442)
- Nataly Naser Al Deen (ORCID: https://orcid.org/0000-0003-0666-4791)
- Katie Marie Campbell (ORCID: https://orcid.org/0000-0001-6491-4432)
- Egmidio Medina (ORCID: https://orcid.org/0000-0002-3284-5329)
- Antoni Ribas (ORCID: https://orcid.org/0000-0003-3669-8458)
- William G. Kaelin (ORCID: https://orcid.org/0000-0002-0574-4856)
- Carter Ching (ORCID: https://orcid.org/0009-0008-9117-3025)
- Yichen Fan (ORCID: https://orcid.org/0009-0004-2004-7815)
Institutions
- Gladstone Institutes (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Dana-Farber Cancer Institute (US)
- Max Planck Institute of Biochemistry (DE)
- University of San Francisco (US)
Publication Details
- Journal
- Cancer Immunology Research
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1158/2326-6066.cir-26-0181
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00